GrowingStockReport.com

Array BioPharma, Inc. (NASDAQ:ARRY) and Endocyte, Inc. (NASDAQ:ECYT) Added to Growing Stock Report's NASDAQ Gainers Watch List.

 

New York, NY -- (ReleaseWire) -- 03/25/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Array BioPharma, Inc. (NASDAQ:ARRY) and Endocyte, Inc. (NASDAQ:ECYT).

Array BioPharma, Inc. (NASDAQ:ARRY) a biopharmaceutical company that focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases primarily in North America, Europe, and the Asia Pacific is currently up (+8.62%) on 1,441,929 shares traded after Array BioPharma was upgraded to Overweight from Neutral at Piper Jaffray. Array BioPharma, Inc. (NASDAQ:ARRY) is currently up (+63.33%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Array BioPharma, Inc. (NASDAQ:ARRY)

Endocyte, Inc. (NASDAQ:ECYT) a biopharmaceutical company that develops targeted therapies for the treatment of cancer and inflammatory diseases is currently up (+7.78%) on 287,939 shares traded after Endocyte was upgraded to Outperform from Neutral at RW Baird. Endocyte, Inc. (NASDAQ:ECYT) is currently up (+197.05%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Endocyte, Inc. (NASDAQ:ECYT)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com